F832-0870 Screening compound: 1-(4-cyclohexylpiperazino)-3-(9-phenylpyrazolo[1,5-a][1,2,4]triazolo[3,4-c]pyrazin-3-yl)-1-propanone

F832-0870 Screening compound: 1-(4-cyclohexylpiperazino)-3-(9-phenylpyrazolo[1,5-a][1,2,4]triazolo[3,4-c]pyrazin-3-yl)-1-propanone
F832-0870 Screening compound: 1-(4-cyclohexylpiperazino)-3-(9-phenylpyrazolo[1,5-a][1,2,4]triazolo[3,4-c]pyrazin-3-yl)-1-propanone alternative view

Chemical Structure Depiction of ChemDiv screening compound F832-0870
1-(4-cyclohexylpiperazino)-3-(9-phenylpyrazolo[1,5-a][1,2,4]triazolo[3,4-c]pyrazin-3-yl)-1-propanone

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F832-0870

Molecular Formula

C26H31N7O (C26 H31 N7 O)

Compound Name

1-(4-cyclohexylpiperazino)-3-(9-phenylpyrazolo[1,5-a][1,2,4]triazolo[3,4-c]pyrazin-3-yl)-1-propanone

IUPAC name

1-(4-cyclohexylpiperazin-1-yl)-3-{11-phenyl-346910-pentaazatricyclo[7.3.0.0^{26}]dodeca-1(12)24710-pentaen-5-yl}propan-1-one

SMILES

O=C(CCc1nnc(c2c3)n1ccn2nc3-c1ccccc1)N(CC1)CCN1C1CCCCC1

InChI

InChI=1S/C26H31N7O/c34-25(31-15-13-30(14-16-31)21-9-5-2-6-10-21)12-11-24-27-28-26-23-19-22(20-7-3-1-4-8-20)29-33(23)18-17-32(24)26/h1,3-4,7-8,17-19,21H,2,5-6,9-16H2

InChI Key

NQZNTGOKLLFCFB-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27197355

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

457.58

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.370

Distribution Coefficient, logD

2.072

Water Solubility, LogSw

-2.56

Polar Surface Area

53.188

Acid Dissociation Constant (pKa)

23.47

Base Dissociation Constant (pKb)

7.40

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.20

F832-0870 in Drug Discovery

Included in Screening Libraries

GPCR Targeted Library (31838 compounds)

Regenerative Medicine Focused Library (23016 compounds)

SmartTM Library (51161 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
Targets:
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with F832-0870 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F832-0870?
Check Price and Availability of F832-0870, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F832-0870 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F832-0870
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F832-0870
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F832-0870 available by request